Shaanxi Kanghui Pharmaceutical Co., Ltd. Announcement on Pledge of Part of Controlling Shareholder's Shares

robot
Abstract generation in progress

Log in to the Sina Finance app, search 【information disclosure】 to view assessment tiers

Stock code: 603139 Stock abbreviation: Kanghui Co., Ltd. Announcement No.: 2026-014

Shaanxi Kanghui Pharmaceutical Co., Ltd.

Announcement on Partial Share Pledge by the Controlling Shareholder

The board of directors of the Company and all of its directors warrant that there are no false records, misleading statements, or material omissions in the contents of this announcement, and assume legal responsibility for the truthfulness, accuracy, and completeness of its contents.

Key Matters to Note:

● As of the date of disclosure of this announcement, Jiaxing Yuehe Zhichuang Technology Partnership (Limited Partnership) (hereinafter referred to as “Yuehe Zhichuang”), the controlling shareholder of Shaanxi Kanghui Pharmaceutical Co., Ltd. (hereinafter referred to as the “Company”), holds 21,973,600 shares of the Company’s unrestricted tradable shares, accounting for 22% of the Company’s total share capital.

● In this pledge, Yuehe Zhichuang pledged 6,200,000 shares of the Company (representing 6.2074% of the Company’s total share capital). After this pledge, Yuehe Zhichuang has cumulatively pledged 12,294,500 shares of the Company, accounting for 55.9512% of the shares it holds and 12.3093% of the Company’s total share capital.

I. Specific Circumstances of This Share Pledge

On April 1, 2026, the Company received a notice letter from Yuehe Zhichuang, and learned that Yuehe Zhichuang pledged 6,200,000 shares of the Company it held to Hangzhou Baotong Pawnshop Co., Ltd. The details are as follows:

  1. Basic Information of This Share Pledge

The registration procedures for this pledge have been completed with China Securities Depository and Clearing Corporation Limited; this pledged share does not involve matters such as guarantees for major asset restructuring performance compensation.

  1. Cumulative Pledged Shares of Shareholders

As of the date of disclosure of this announcement, the cumulative pledged shares of Yuehe Zhichuang are as follows:

II. Pledge Circumstances of the Company’s Controlling Shareholder

  1. As of the date of disclosure of this announcement, the controlling shareholder Yuehe Zhichuang has cumulatively pledged 12,294,500 shares of the Company, representing 55.9512% of the total number of shares it holds and 12.3093% of the Company’s total share capital. Among them, the financing amounts corresponding to the 6,094,500 shares from the prior pledge have all been repaid, and the pledge term has expired. However, due to personal reasons of the pledgee, the relevant procedures for releasing the pledge have not yet been handled. The Company will promptly advance and complete the release of the pledge. After the prior shares are released, the number of shares pledged by Yuehe Zhichuang that will mature within the next year is 6,200,000 shares, representing 28.2157% of its total number of shares held and 6.2074% of the Company’s total share capital.

  2. As of the date of disclosure of this announcement, the controlling shareholder Yuehe Zhichuang does not have any circumstances that would impair the Company’s interests, such as non-operating fund occupation, illegal guarantees, or related-party transactions.

  3. Impact of the Controlling Shareholder’s Pledge on the Company

Yuehe Zhichuang’s credit standing is good and it has the corresponding capacity to repay funds. This pledge will not affect the Company’s normal production and operation. The pledged shares do not involve obligations for performance compensation such as those for major asset restructuring. At present, there is no risk of liquidation (forced closing) or risk of compulsory transfer. The risk of the share pledge is within a controllable range and will not lead to a change in the Company’s actual controlling right. The Company will continue to monitor Yuehe Zhichuang’s share pledge situation and risks, and will fulfill its information disclosure obligations in a timely manner in accordance with relevant regulations. Investors are kindly reminded to pay attention to investment risks.

Announcement is hereby given.

Board of Directors of Shaanxi Kanghui Pharmaceutical Co., Ltd.

April 2, 2026

A huge amount of information and precise interpretation—available on the Sina Finance app

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments